Skip to main content

Table 4 Covariates of completion of isoniazid prevention therapy

From: A prospective cohort study of outcomes for isoniazid prevention therapy: a nested study from a national QI collaborative in Uganda

VariableCoefficientp-valuedfAOR95% CI
Age (years)
 < 15− 0.8770.23010.416(0.099–1.745)
 ≥ 150.0001.000
Gender
 Females0.4690.01811.598(0.896–2.470)
 Male0.0001.000
Kept all appointments
 Yes2.3730.000110.726(0.112–0.791)
 No0.0001.000
Side effects
 No0.6720.01611.958(0.17–1.393)
 Yes0.0001.000
Adherence score ≥ 95%
 Yes0.4230.01311.526(0.647–1.644)
 No0.0001.000